1. Signaling Pathways
  2. Neuronal Signaling
  3. Monoamine Oxidase
  4. Monoamine Oxidase Inhibitors

Monoamine Oxidase Inhibitors

MAO-A

MAO-B

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Monoamine Oxidase Inhibitors
Product Name MAO-A MAO-B Purity
Tranylcypromine hydrochloride
MAO-A, IC50: 2.3 μM
MAO-B, IC50: 0.95 μM
Pargyline hydrochloride
MAO-A, Ki: 13 μM
MAO-B, Ki: 0.5 μM
99.91%
Rasagiline mesylate
rMAO-A, IC50: 412 nM
rMAO-B, IC50: 4.43 nM
99.66%
Moclobemide
MAO-A, IC50: 6.061
  99.63%
Safinamide
MAO-A, IC50: 580 μM
MAO-B, IC50: 98 nM
99.95%
Pargyline
MAO-A, Ki: 13 μM
MAO-B, Ki: 0.5 μM
99.82%
Rasagiline
rMAO-A, IC50: 412 nM
rMAO-B, IC50: 4.43 nM
99.88%
Norharmane
MAO-A, IC50: 6.5 μM
MAO-B, IC50: 4.7 μM
98.49%
MAO-IN-M30 dihydrochloride
MAO-A, IC50: 37 nM
MAO-B, IC50: 57 nM
99.25%
Safinamide mesylate
MAO-A, IC50: 580 nM
MAO-B, IC50: 98 nM
99.18%
Harmane
hMAO-A, IC50: 0.5 μM
MAO-B, IC50: 5 μM
99.81%
Osthenol
hMAO-A, IC50: 0.74 μM
hMAO-A, Ki: 0.26 μM
  98.91%
Methyl citrate  
MAO-B, IC50: 0.23 mM
≥98.0%
Ladostigil  
MAO-B, IC50: 37.1 μM
Bifemelane hydrochloride
MAO-A, Ki: 4.2 μM
MAO-B, Ki: 46 μM
98.83%
Ladostigil hemitartrate  
MAO-B, IC50: 37.1 nM
MAO A/HDAC-IN-1
MAO-A
 
MAO-A/5-HT2AR-IN-1
MAO-A, IC50: 0.004 ± 0. μM
MAO-B, IC50: 1.05 ± 0.0 μM
Dual AChE-MAO B-IN-2  
MAO-B, Ki: 4.5 μM
MAO-B-IN-9  
MAO-B, IC50: 0.178 ± 0. μM
LSD1-IN-17
MAO-A, IC50: 0.028 ± 0. μM
MAO-B, IC50: 0.820 ± 0. μM
(±)-Amiflamine
MAO-A, pIC50: 5.57
 
MAO-B-IN-13  
MAO-B, IC50: 10 nM
Neuroinflammatory-IN-2  
MAO-B, IC50: 10.30 μM
hMAO-B-IN-2  
MAO-B, IC50: 4 nM
MAO-B-IN-16
hMAO-A, IC50: >100 μM
hMAO-B, IC50: 1.55 μM
1-Methyl-2-undecyl-4(1H)-quinolone  
MAO-B, IC50: 15.3 μM
MAO-B, Ki: 9.91 μM
LSD1-IN-15
MAO-A, IC50: 0.028 ± 0. μM
MAO-B, IC50: 0.327 ± 0. μM
MAO-B-IN-7  
MAO-B, IC50: 0.3 μM
MAO-B-IN-14  
hMAO-B, IC50: 0.95 μM
hMAO-B, Ki: 0.55 μM
MAO-B-IN-8  
MAO-B
MAO-B-IN-11  
MAO-B, IC50: 1.3 μM
MAO-B-IN-10
MAO-A, IC50: 15.9 ± 0.1 μM
MAO-B, IC50: 5.3 ± 0.22 μM
HDAC1/MAO-B-IN-1  
MAO-B, IC50: 99.0 nM
MAO-B-IN-5
MAO-A, IC50: 0.204 μM
MAO-B, IC50: 34.190 μM
Dual AChE-MAO B-IN-3  
MAO-B, IC50: 0.41 ± 0.0 μM
2-PAT
MAO-A, IC50: 0.721 μM
MAO-B, IC50: 14.6 μM
(E)-8-(3-Chlorostyryl)caffeine  
MAO-B, Ki: 70 nM
AChE/BChE-IN-6  
hMAO-B, IC50: > 100 μM
1-Methyl-2-nonyl-4(1H)-quinolone
MAO-A
MAO-B
MAO-B-IN-17
hMAO-A, IC50: >100 μM
hMAO-B, IC50: 5.08 μM
AChE/BuChE/MAO-B-IN-1  
hMAO-B, IC50: 1.11 μM
Moclobemide N-Oxide
MAO-A
 
FTEAA
MAO-A, IC50: 0.52 μM
MAO-B, IC50: 1.02 μM
Chrysophanol-1-O-β-gentiobioside
MAO-A, IC50: 96.15 μM
 
MAO-B-IN-6
MAO-A, IC50: 46.365 μM
MAO-B, IC50: 0.019 μM
LSD1-IN-12
MAO-A, Ki: 2.3 μM
MAO-B, Ki: 3.5 μM
AChE/BChE/MAO-B-IN-1  
MAO-B, IC50: 26.1 μM
MAO-B-IN-15
hMAO-A, IC50: >100 μM
hMAO-B, IC50: 13.5 μM
Monoamine Oxidase B inhibitor 2
MAO-A, IC50: 1150 nM
MAO-B, IC50: 1.33 nM
H3R antagonist 2  
MAO-B, IC50: 775 nM
Monoamine Oxidase B inhibitor 1
MAO-A, IC50: 810 nM
MAO-B, IC50: 0.02 nM
Lazabemide hydrochloride  
MAO-B, IC50: 0.4 nM
MAO-B-IN-12  
MAO-B, IC50: 1.3 μM
Monoamine oxidase/Aromatase-IN-1  
MAO-B, IC50: 39 nM
LSD1-IN-16
MAO-A, IC50: 0.024  ±   μM
MAO-B, IC50: 0.366  ±  μM
5-HT6R/MAO-B modulator 1  
MAO-B